Receiver operating characteristic (ROC) analysis of early onset chronic GVHD biomarkers
| Biomarker . | AUC . | Biomarker concentrationat 90% specificity . | Sensitivityat 90% specificity* . |
|---|---|---|---|
| Anti-dsDNA | 0.66 | 1.8 IU/mL | 49% |
| sIL-2Rα | 0.83 | 8.39 pg/mL | 47% |
| sCD13 | 0.77 | 0.43 units/mL | 53% |
| sBAFF | 0.70 | 6.64 pg/mL | 42% |
| Biomarker . | AUC . | Biomarker concentrationat 90% specificity . | Sensitivityat 90% specificity* . |
|---|---|---|---|
| Anti-dsDNA | 0.66 | 1.8 IU/mL | 49% |
| sIL-2Rα | 0.83 | 8.39 pg/mL | 47% |
| sCD13 | 0.77 | 0.43 units/mL | 53% |
| sBAFF | 0.70 | 6.64 pg/mL | 42% |
All negatives have a false positive rate of <10% (specificity).